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Background: Splenic epidermoid cyst is a benign tumor-like lesion affecting the spleen and sometimes occurs in
familial form. The causality of such rare diseases remain challenging, however recently, with the emergence of
exome re-sequencing, the genetics of many diseases have been unveiled. In the present study, we performed a
combinatorial approach of genome-wide parametric linkage and exome analyses for a moderate-sized Japanese
family with frequent occurrence of splenic epidermoid cyst to identify the genetic causality of the disease.
Methods: Twelve individuals from the family were subject to SNP typing and exome re-sequencing was done for 8
family members and 4 unrelated patients from Kosovo. Linkage was estimated using multi-point parametric linkage
analysis assuming a dominant mode of inheritance. All of the candidate variants from exome analysis were
confirmed by direct sequencing.
Results: The parametric linkage analysis suggested two loci on 1q and 14q with a maximal LOD score of 2.5 .
Exome generated variants were prioritized based on; impact on the protein coding sequence, novelty or rareness in
public databases, and position within the linkage loci. This approach identified three variants; variants of HMCN1 and
CNTN2 on 1q and a variant of DDHD1 on 14q. The variant of HMCN1 (p.R5205H) showed the best co-segregation in the
family after validation with Sanger sequencing. Additionally, rare missense variants (p.A4704V, p.T5004I, and p.H5244Q)
were detected in three unrelated Kosovo patients. The identified variants of HMCN1 are on conserved domains,
particularly the two variants on calcium-binding epidermal growth factor domain.
Conclusions: The present study, by combining linkage and exome analyses, identified HMCN1 as a genetic
causality of splenic epidermoid cyst. Understanding the biology of the disease is a key step toward developing
innovative approaches of intervention.
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Mendelian disorders are classically analyzed by linkage ana-
lysis to determine genetic loci and subsequently positional
cloning to identify the causal variants. With the advent of
deep sequencing technologies, re-sequencing of entire
human genome could become a powerful tool to identify
variants underlying monogenic and probably common* Correspondence: itinoue@nig.ac.jp
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unless otherwise stated.disorders. Although protein-coding regions constitute ap-
proximately 1% of the human genome, 85% of the variants
with substantial effects on disease-related traits locate on
those regions [1]. Accordingly, exome re-sequencing has
increasingly been used as an efficient way to identify genetic
causes of diseases [2,3]. However, exome re-sequencing
alone would still leave a considerable number of candi-
date variants. In the current study, we performed exome
re-sequencing, in samples from a Japanese family and 4
unrelated Kosovar having splenic epidermoid cyst, in com-
bination with genome-wide parametric linkage analysis as
filtering procedure, to identify the genetic causality [4].
Splenic epidermoid cyst is a very rare benign tumor-like
lesion filled with fluid or semi-fluid material (Figure 1). Ittd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Clinical features of splenic epidermoid cyst. (A) Photograph of the surgical specimen from the spleen of the proband (IV:3) of the Japanese
family. (B) Abdominal ultrasound image showing the splenic cysts of IV:3. Multiple tumor-like lesions were seen filled with liquid or semi-liquid material
and pathological examination showed that the walls of the cysts consisted of vitrificated fibrous connective tissues, lined by stratified squamous epithelia.
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dominance [5]. Most cases are asymptomatic and the clin-
ical symptoms are dependent on the size of the cyst. Cysts
larger than 5 cm, as well as symptomatic and complicated
cysts that may cause hemorrhage, rupture, or infection,
should be surgically treated [6,7]. While cysts are usually
singular, multiple cysts have been observed especially in
familial cases. Splenic cysts are much less common than
those arising in kidney, liver, or ovary [8], and the molecular
etiology of this condition is mostly unknown. A possible
etiology of the cyst formation is attributed to developmen-
tal stages when misplacement of epithelial tissue occurs
and also to metaplasia [9], however, the developmental
origin of the epidermoid cysts of the spleen is unclear. Thus
far, several affected parent–child and sibs have been
reported [9-14], suggesting that genetic factors are possibly
involved in predisposition to the disease. In the current
study, in order to decipher the genetic factor, we recruited
a Japanese family with frequent occurrences of splenic epi-
dermoid cyst and performed genome-wide linkage analysis
and exome capture followed by massive parallel sequen-
cing. A series of filtering steps identified three candidate
genes and then patients recruited in Kosovo were used for
replication to finally identify a single candidate gene.
Methods
Study subjects
A three-generation Japanese family comprising seventeen
members (five males/twelve females), including six
patients of splenic epidermoid cyst, was recruited at
Health Insurance Hitoyoshi General Hospital, KumamotoPrefecture, Japan. The proband (IV:3), a 16-year-old girl, ex-
hibited abdominal pain during exercise and later diagnosed
as having multiple epidermoid cysts in spleen using ultra-
sonography and CT scan (Figure 1). Laboratory data of the
patient’s serum showed elevated level of carbohydrate anti-
gen 19–9 (CA19-9) i.e. 329 units/ml (<37 units/ml), which
returned to the normal range after splenectomy. Since the
proband’s father (III:2) was diagnosed with the disease and
treated with splenectomy, we started extending recruitment
to the other family members. Recruited members were
examined for splenic cysts by ultrasound or at least clinical
examination of the spleen in case of ultrasound was not pos-
sible. In addition to this Japanese family, we ascertained four
DNA samples of unrelated affected individuals from Kosovo.
The patients underwent surgery and their final diagnosis
was pathologically confirmed with the resected specimens.
Considering the rarity of splenic cyst, increasing the sam-
ple size, particularly from a different population, would
strengthen the significance of the findings. The study was
approved by the ethical committees of the Health Insurance
Hitoyoshi General Hospital, University Clinical Center of
Kosovo, Prishtina University, School of Medicine, and the
Tokai University, School of Medicine. All of the participants
or their guardians gave written informed consent.
SNP genotyping and linkage analysis
Genomic DNA was extracted from peripheral blood or
saliva samples according to the standard protocol. The
DNA samples (250 ng) from 12 family members were
subjected to genotyping using the Genome-Wide Human
SNP Array 5.0 (Affymetrix, Santa Clara, CA, USA) following
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II:1, II:2, II:4, II:6, III:1, III:2, III:3, IV:2, IV:3, IV:4, IV:5, and
IV:6 (Figure 2). III:3 is an unaffected individual but also the
father of the affected child (IV:6). We assumed III:3 is a
carrier of the causal variant but we assigned him as
unaffected in the linkage analysis. A total of 443,816 single
nucleotide polymorphisms (SNPs) were genotyped.
Then monomorphic or X-linked SNPs and SNPs show-
ing Mendelian inconsistencies were excluded; leaving
274,743 SNPs for further analysis. However there were
some concerns about performing linkage with such number
of SNPs (i.e. inflation of linkage statistics due to linkage
disequilibrium [15], effect of typing errors, and impractical
use of memory). To circumvent these difficulties, we di-
vided the data into 30 subsets by taking one SNP every 30
successive SNPs; Thus, around 9,200 SNPs in each dataset
at interval of approximately 0.34 Mb (see Additional file 1).
We then performed the linkage analysis on each of the 30
subsets, and calculated the average LOD scores of all the
subsets. Looking at the affection status in the family’s pedi-
gree indicated that the dominant mode of inheritance was
most conceivable. We performed multi-point parametric
linkage analysis using MERLIN 1.1.2 [16] with penetrance
levels setting as follows: under a dominant mode, 0.95
for Aa and aa genotypes (A and a denote wild-type and
mutant alleles, respectively) and 0.005 for AA genotype.
Considering rarity of the disease, frequency of disease-
causing allele was set to 5.0 × 10−3.
Exome re-sequencing and data analysis
For exome re-sequencing, we selected eight individuals
form the Japanese family (II:1, II:2, II:3, II:5, III:1, III:2,
IV:3, and IV:4), which included four affected members. In
addition, exome re-sequencing was done for four unrelated
affected individuals from Kosovo. Starting with 3 μg ofFigure 2 Pedigree of a Japanese family with splenic epidermoid cyst
and circles denote affected individuals and open symbols represent unaffe
are for the R5205H variant of HMCN1, which is co-segregating with the affethe DNA, samples were subject to exome capture using
Sure-Select Human All Exon Kit (Agilent Technologies,
Santa Clara, CA, USA), according to the manufacturer’s
procedures. The captured DNA was sequenced using
HiSeq 2000 (illumina, San Diego, CA, USA). The reads
were mapped to the reference genome (UCSC hg19) using
BWA v.0.5.7 [17]. BWA generated SAM files were sorted
and indexed using SAMtools v.0.1.7a [18] then duplicated
reads were marked with Picard v.1.102 [19]. The files ob-
tained in BAM format were analyzed using GATK v.2.7 fol-
lowing their best practices guidelines [20]. In brief, the BAM
files were first subject to indel realignment, base quality
score recalibration, and then variants calling with the
Unified Genotyper walker, to obtain the potential vari-
ants in a VCF file. Variants in VCF files were annotated
using the algorithm (table.annovar.pl) in ANNOVAR
(version 2013jul21) [21]. For annotation of genes, we
used RefSeq gene database (build hg19) [22], while variants’
annotation was based on dbSNP (dbSNP 137) and 1000
Genomes Project databases [23].
Sanger sequencing
We examined all the family members by Sanger sequencing
to confirm the finding as well as co-segregation of the vari-
ants with the disease status. PCR primers, flanking approxi-
mately 300 bp of the final candidate variants, were designed
using Primer3Plus [24] and the target sequences were amp-
lified by PCR then sequenced using Sanger method on the
3730 DNA Analyzer (Applied Biosystems, Tokyo, Japan).
Results
Genome-wide linkage analysis
The average LOD scores of the parametric genome-wide
linkage analysis are presented in Figure 3A. Based on a
dominant model, a linkage signal with maximal LODand co-segregation of R5205H variant of HMCN1. Filled squares
cted subjects. The arrow indicates the proband (IV:3). The genotypes
ction status except for III-3, III-4, and IV-1.
Figure 3 Plots of SNP-based genome-wide linkage analyses. (A) LOD scores from the genome-wide multi-point parametric linkage analysis.
The horizontal dotted line indicates the threshold LOD = 1.90 which was used in linkage analysis. (B) Enlarged plots of the average LOD scores of
the two chromosomes 1 and 14, in which suggestive evidence of linkage was observed. A maximal LOD score of 2.50 was observed at 1q
(rs12408625-rs11119748; 181,329,186-211,652,185 bp) and 14q (rs2415328-rs7148027; 36,888,532-56953253 bp).
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(rs12408625-rs11119748; 181,329,186-211,652,185 bp) and
14q (rs2415328-rs7148027; 36,888,532-56,953,253 bp)
(Figure 3B). Although the LOD scores did not reach the
widely accepted significant LOD score of 3, the LOD
score of 2.5 is assumed to be suggestive evidence of
linkage. The loci identified on chromosomes 1 and 14
were then used in exome analysis as a filtering criterion
for candidate variants identification.
Exome analysis
We performed exome analysis for a total of 12 individuals;
8 Japanese family members and 4 unrelated cases from
Kosovo. After mapping to the reference genome, approxi-
mately 7 Gb of sequences were obtained, which have a 93%
coverage of all exons with depth of at least 20 reads and
seemed to be sufficient for further analyses. After annota-
tion of variants, we performed sequential filtering steps
based on the following criteria; first, based on the variant’s
impact on the protein coding sequence; it is likely that the
causal variant is an amino acid substitution, frame-shiftmutation, or splicing site alteration, second, because fa-
milial splenic epidermoid cyst is a very rare disease, it is
likely that the causal variant either has a low population
frequency or not registered in public databases. Con-
sidering the previous criteria, we applied two separate
filters; one for the novel variants that have not been re-
ported previously in dbSNP (dbSNP 137) or 1000 Genomes
databases, while the second one for variants with minor
allele frequency (MAF) of up to 2% in the Japanese or
European population according to 1000 Genomes data-
base. Finally, we utilized the linkage data by selecting
only variants within the previously identified loci on
chromosomes 1 (181,329,186-211,652,185 bp) and 14
(36,888,532-56,953,253 bp). This approach of combining
linkage and exome analyses has been useful in reducing
the number of investigated variants [25]. Furthermore,
only variants that are consistently co-segregating with
the disease (i.e. shared by all the cases and absent in the un-
affected ones) were selected as candidates. Ultimately, three
variants were identified; two variants on chromosome 1
and one variant on chromosome 14 (Table 1).
Table 1 Number of variants obtained using different filters in a family of splenic epidermoid cyst
Criteria for variants filtering AFFECTED NOT AFFECTED UNCONFIRMED*
III:2 IV:3 IV:4 II:2 III:1 II:1 II:3 II:5
Total (Exonic, Splicing) 22903 23110 22925 22686 22705 23389 22900 22748
SNVs (NS, SC) 10735 10836 10679 10576 10641 10939 10630 10576
Not in dbSNP or 1000 Genomes 630 625 606 606 576 687 648 664
Within linkage region
Chr. 1: 181,329,185-211,652,186 bp 8 6 8 9 8 6 7 6
Chr. 14: 36,888,531-58,397,917 bp 5 4 2 2 3 3 4 2
Shared by all AFFECTED 2 (CNTN2 & DDHD1) 2 2 2 - - 1 (DDHD1) 1
INDELs (FS, non-FS) 218 222 224 232 231 226 232 235
Not in dbSNP or 1000 Genomes 23 25 26 23 19 31 32 25
Within linkage region
Chr. 1: 181,329,185-211,652,186 0 0 0 0 0 1 0 0
Chr. 14: 36,888,531-58,397,917 0 0 0 0 0 0 0 0
Rare variants
Total (NS, SC, FS, Non-FS) 352 360 350 335 337 352 336 367
Within linkage region
Chr. 1: 181,329,185-211,652,186 3 5 5 6 4 5 8 11
Chr. 14: 36,888,531-58,397,917 0 0 0 0 0 0 0 0
Shared by all AFFECTED 1 (HMCN1) 1 1 1 - - - -
Exonic and splicing site variants were filtered based on being single nucleotide variants (SNVs) including non-synonymous (NS) and stop codon (SC) variants, while
insertion/deletion (INDELs) including frame-shift (FS) and non-frame-shift (non-FS) variants. Novel variants were those not reported in dbSNP database (dbSNP 137) and
rare variants (up to 2%) filter is based on the Japanese allele frequencies data from 1000 Genomes database. *Those family members were set as UNCONFIRMED
because their affection status was based on clinical examination of the spleen.
Table 2 Number of variants obtained using different
filters in subjects affected by splenic epidermoid cyst
from Kosovo
Criteria for variants filtering Kos-1 Kos-2 Kos-3 Kos-4
Total (Exonic, Splicing) 14817 14427 14783 14277
SNVs (NS, SC) 6701 6562 6734 6526
Not in dbSNP or 1000
Genomes (novel)
239 191 245 258
Up to 2% in 1000 Genomes 368 378 358 323
INDELs (FS, non-FS) 29 47 42 58
Not in dbSNP or 1000
Genomes (novel)
27 44 40 58
Up to 2% in 1000 Genomes 0 0 0 0
Exonic and splicing site variants were filtered based on being single
nucleotide variants (SNVs) including non-synonymous (NS) and stop codon
(SC) variants, while insertion/deletion (INDELs) including frame-shift (FS) and
non-frame-shift (non-FS) variants. Novel variants were those not reported in
dbSNP database (dbSNP 137) and rare variants filter is based on the European
allele frequencies data from 1000 Genomes database.
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novel and the other was a rare variant. The novel variant
(c.G361A, p.V121I) is located in the Contactin 2 gene
(CNTN2) and it causes an amino acid substitution at
exon 4. Similarly, the rare non-synonymous variant
(rs150188026, c.G15614A, p.R5205H, MAF 0.018) is lo-
cated in the Hemicentin 1 gene (HMCN1) and it causes an
amino acid substitution at exon 101. Exome analysis of the
Kosovo samples, revealed neither novel nor rare variants in
CNTN2, but three of the four samples harbor very rare
missense variants in HMCN1 (c.C14111T, p.A4704V, MAF
0.001; c.C15011T, p.T5004I, MAF 0.008, and c.C15732G,
p.H5244Q, MAF 0.005) (Table 2 and Table 3). The other
identified novel variant of chromosome 14 is located
to the DDHD domain containing 1 gene (DDHD1)
(c.T1178C, p.V393A) and it causes an amino acid substitu-
tion at exon 4. However, examining Kosovo samples for
variants in DDHD1 did not reveal any novel or rare variants
as defined by the previous criteria. Considering DDHD1 is
an enzyme protein, it was possible to evaluate the variant’s
impact by measuring the enzymatic activity. Functional im-
pact of DDHD1 variant (V393A) was evaluated by measur-
ing activity of phospholipase A1 using phosphatidic acid as
substrate, and no significant effect on the enzymatic activity
of the variant protein was detected (data not shown).Sanger sequencing confirmation and co-segregation
We also performed Sanger sequencing to confirm the three
candidate variants obtained from exome sequencing for all
of the family members and Kosovo patients. Both V121I
variant of CNTN2 and R5205H of HMCN1 showed consist-
ent co-segregation with the affection status except III:3,
Table 3 HMCN1 identified variants and scores of GERP and pathogenicity prediction tools
Substitution Variant ID Sample MAF GERP SIFT PolyPhen-2
R5205H rs150188026 II:2, II:6, III:2, IV:3, IV:4, IV:6 0.018 2.02 0.34 0.019
T5004I rs114629728 Kos-2 0.005-0.011 2.56 0.29 0.175
H5244Q rs75161007 Kos-3 0.005-0.022 0.69 0.60 0.010
A4704V rs41317503 Kos-4 0.001 5.47 0.04 0.774
Abbreviations: MAF Minor allele frequency (based on 1000 Genomes allele frequencies for Japanese and European populations), GERP Genomic evolutionary
rate profiling.
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variants is co-segregating without recombination in the
family (Figure 2). The incompleteness of co-segregation in
III:3 who is an unaffected male with heterozygote genotype
but also the father of the affected 14 years old child (IV:6).
Inconsistency of co-segregation in III:3 and III:4 family
members may be due to the incomplete penetrance of
the disease. The variant V393A of DDHD1 is less con-
sistently co-segregated with II:3, II:5, III:3, and III:5 hav-
ing a heterozygote genotype while they are unaffected
(see Additional file 2). We further focused on HMCN1
because it showed a better co-segregation with the disease
and other variants were detected in Kosovo samples there-
fore it seemed a good candidate for disease causality.
HMCN1 variants’ genomic context, conservation,
and pathogenicity
Using InterPro database to predict the genomic context
of the variants, all of the identified HMCN1 variants are
located within conserved domains [26]. Two of the variants,
R5205H and H5244Q, are located on the calcium-binding
Epidermal Growth Factor (cb-EGF) like domain, while the
variant, A4704V, is located on the Thrombospondin
type 1 (TSP1) domain and the variant, T5004I, is on the
G2 nidogen domain (Figure 4). Sequence homology of
the variants’ vicinities between several species showed a
relatively high conservation among mammalian species
(Figure 4). Furthermore, annotation of variants’ across-
species conservation, using Genomic Evolutionary Rate
Profiling (GERP) score as a measurement, revealed that
most of the variants have relatively moderate conservation
scores, which ranges from 0.69 to 5.47 (Table 3). We also
used the pathogenicity prediction tools SIFT [27] and
PolyPhen2 [28] to predict the impact of HMCN1 variants
on the protein activity (Table 3).
Discussion
Splenic epidermoid cyst is a very rare disease and we
recruited a three-generation Japanese family comprising
six patients. In the study, we first performed genome-wide
parametric linkage analysis to narrow down the candidates
loci. We then performed exome re-sequencing for eight
individuals from the family in addition to four unrelated
affected individuals from Kosovo. Based on stringentfiltering steps on the exome data, in combination with
linkage results, three variants of CNTN2, HMCN1, and
DDHD1 were initially identified in the family. Because we
could not pinpoint to one gene, it was necessary to find
additional evidence supporting their possible role in the
disease. We considered if any of the Kosovo unrelated
samples has a novel or rare variant in the same gene that
would prioritize the gene as candidate. Interestingly, we
found rare missense variants in only HMCN1 in both the
affected Japanese and three Kosovo cases.
HMCN1 (also known as Fibulin 6) is a large extracellular
member of the immunoglobulin superfamily and it contains
around 5,635 amino acids (600 kD) [29] [UniProtKB:
Q96RW7]. This protein belongs to a family known as
fibulins, a group of related proteins involved in many
cellular processes such as cell adhesion, migration, and
proliferation [30]. Expression of HMCN1 mRNA in the
human spleen is relatively higher than other organs [31],
and HMCN1 protein was detectable in the pericellular
extracellular matrix of mouse epithelial cells in many
tissues [32]. Function of human HMCN1 is still not
well investigated, however a similar protein in C. elegans
forms fine tracks that are mainly involved in stabilizing
and organizing extracellular matrix of the epidermis [29].
Variants of HMCN1 have been reported to associate with
age-related macular degeneration, a phenotype that is char-
acterized by extracellular deposits of proteins and lipids in
the eye [33]. Studies from zebrafish also revealed that
variants of Hmcn1 caused a phenotype named fin blistering
[34], which is a fluid-filled structure encompassed by a layer
of epithelial cells. Considering that splenic epidermoid cyst
has a structure filled with fluids and lined by a layer of epi-
thelial cells, these phenotypic similarities with the previous
observations would support the possible involvement of
HMCN1 in the etiology of splenic epidermoid cyst.
The molecular mechanism by which HMCN1 is likely
involved in splenic epidermoid cyst still remains unknown.
However, one scenario that might explain the implication
of HMCN1 is related to its function as an extracellular
matrix protein. As noted previously, one of the hypotheses
of splenic cyst formation is that a misplacement of epithe-
lial cells during developmental stages. Bearing that in
mind, it is possible that such misplacement could be due
to instability of HMCN1 structure caused by the variants
Figure 4 Genomic context of HMCN1 domains and variants with their across-species conservation. (A) Domain structures of partial HMCN1 are
illustrated. TSP1 denotes thrombospondin type 1 domain and cb-EGF denotes calcium-binding epidermal growth factor like domain. The repetitive
Immunoglobulin like (Ig-like) domain is also presented. (B) The genomic context of HMCN1 variants and the corresponding amino acid substitutions
with their physical position. (C) Across-species conservation of the variants’ positions indicating a conserved pattern except for chicken and zebrafish.
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cb-EGF, which is mutated in our study subjects, requires
Ca2+ ion for orienting the neighboring domains and
inducing protein conformations required for biological
activities [35]. Interestingly, Ca2+ ion homoeostasis is
known to be a major factor in cyst formation in polycystic
kidney diseases [36].
Our study has a limitation related to the number of sub-
jects involved; because it includes only one family with the
disease, which is basically due to the rarity of the disease.
However, we believe that is compensated by the detection
of variants on the same gene from a completely different
population such as Kosovo population. Further supporting
evidences are warranted to support our hypothesis. Firstly,
more splenic cyst patients need to be screened for variants
in HMCN1. Secondly, functional impact of HMCN1
variants on epidermoid transformation and splenic cyst
formation needs to be experimentally shown. For example,
localization of HMCN1 protein in the cyst’s samples would
be shown with immunohistochemical method. One more
example is using a forward genetic approach to knock out
Hmcn1 from mouse and if such experiment showed a
phenotype similar to splenic cyst, this will clearly en-
force the hypothesis of HMCN1 involvement in splenic
epidermoid cyst etiology.
Conclusions
In the current study, taking the advantage of linkage and
exome analyses, we demonstrated that variants of HMCN1are strong candidates for the causality of splenic epi-
dermoid cyst. To our knowledge, this is the first study
to investigate the genetics of splenic epidermoid cyst
identifying HMCN1 as the causal gene.
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